IMP3 protein is an independent prognostic factor of clinical stage II rectal cancer.
IMP3 protein is an independent prognostic factor of clinical stage II rectal cancer.
复制标题
IMP3蛋白是临床II期直肠癌的独立预后因素。
DOI：
10.1038/s41598-021-90513-y
复制
发表时间：
2021-05-25
影响因子：
4.6
通讯作者：
Tomić S
中科院分区：
文献类型：
--
作者：
Bevanda Glibo D;Bevanda D;Vukojević K;Tomić S
Immunohistochemical level of IMP3-protein in patients with rectal cancer in clinical stage II (141), were correlated with sociodemographic, pathohistological and clinical indicators and duration of overall-survival and progression-free-survival. Vascular invasion was associated with IMP3-positive immunostaining (p < 0.001). Vascular invasion ratio in the group of poorly-differentiated-tumors was 21 times higher than in the group of well-differentiated-tumors. IMP3-positive patients lived 2.2 times shorter than negative (p < 0.001). Patients with well-differentiated-tumors lived 1.7 times longer than the subjects with poorly-differentiated-tumors (p < 0.001). Patients without vascular invasion lived 2.7 times longer than the subjects with vascular invasion (p < 0.001). The risk of mortality was 2.3 times higher for IMP3 positive patients (p = 0.027) and 10.4 higher for the patients with vascular invasion (p < 0.001). IMP3-negative participants had 2.3 times longer free interval without disease (p < 0.001). The free interval without disease was 3.6 times longer in the group without vascular invasion (p < 0.001). The risk of disease relapse in the IMP3 positive group was 5.3 times higher (p < 0.001) and with vascular invasion was 8 times longer (p < 0.001). The risk of disease relapse was 6.8 times higher in the group with vascular invasion (p < 0.001). Patients with rectal cancer and high IMP3-protein level will have a shorter overall survival relative to patients without or with low levels of IMP3. The analysis of IMP3 expression by immunohistochemistry pointed IMP3 as an independent prognostic factor of clinical stage II rectal cancer.
登录
查看更多内容
影响因子：
8.8
作者：
Samanta S;Guru S;Elaimy AL;Amante JJ;Ou J;Yu J;Zhu LJ;Mercurio AM
通讯作者：
Mercurio AM
DOI：
10.1136/bmj.d6617
发表时间：
2011-11-10
期刊：
BMJ (Clinical research ed.)
影响因子：
--
作者：
Aune D;Chan DS;Lau R;Vieira R;Greenwood DC;Kampman E;Norat T
通讯作者：
Norat T
影响因子：
51.1
作者：
Jiang, Zhong;Chu, Peigou G.;Wu, Chin-Lee
通讯作者：
Wu, Chin-Lee
影响因子：
6.6
作者：
Schulze, Susanne;Petersen, Iver
通讯作者：
Petersen, Iver
影响因子：
4
作者：
Chen L;Xie Y;Li X;Gu L;Gao Y;Tang L;Chen J;Zhang X
通讯作者：
Zhang X